- Works count
- 1,125
- Citation count
- 81,087
- H-index
- 118
- i10-index
- 489
Research interests
Publications
Statin therapy is associated with lower prevalence of gut microbiota dysbiosis
Nature · 2020 · https://doi.org/10.1038/s41586-020-2269-x
2018 ESC/EACTS Guidelines on myocardial revascularization
European Heart Journal · 2018 · https://doi.org/10.1093/eurheartj/ehy394
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1609581
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
European Heart Journal · 2017 · https://doi.org/10.1093/eurheartj/ehx419
PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock
New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1710261
2014 ESC/EACTS Guidelines on myocardial revascularization
European Journal of Cardio-Thoracic Surgery · 2014 · https://doi.org/10.1093/ejcts/ezu366
Prehospital Ticagrelor in ST-Segment Elevation Myocardial Infarction
New England Journal of Medicine · 2014 · 10.1056/nejmoa1407024
Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes
New England Journal of Medicine · 2013 · 10.1056/nejmoa1308075
Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary Stenting
New England Journal of Medicine · 2012 · 10.1056/nejmoa1209979
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
New England Journal of Medicine · 2011 · 10.1056/nejmoa1109719
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial
The Lancet · 2010 · 10.1016/s0140-6736(10)61088-4
Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI
JAMA · 2010 · 10.1001/jama.2010.1543
Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate
Journal of the American College of Cardiology · 2010 · 10.1016/j.jacc.2010.04.047
Platelet Inhibition with Cangrelor in Patients Undergoing PCI
New England Journal of Medicine · 2009 · 10.1056/nejmoa0908628
Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial
The Lancet · 2009 · 10.1016/s0140-6736(09)60441-4
Intravenous Platelet Blockade with Cangrelor during PCI
New England Journal of Medicine · 2009 · 10.1056/nejmoa0908629
Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study
The Lancet · 2008 · 10.1016/s0140-6736(08)61845-0
Facilitated PCI in Patients with ST-Elevation Myocardial Infarction
New England Journal of Medicine · 2008 · 10.1056/nejmoa0706816
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
New England Journal of Medicine · 2007 · https://doi.org/10.1056/nejmoa0706482
Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention
Circulation · 2007 · 10.1161/circulationaha.107.740324
Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA Trial
Journal of the American College of Cardiology · 2007 · 10.1016/j.jacc.2007.03.025
Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events
New England Journal of Medicine · 2006 · https://doi.org/10.1056/nejmoa060989
Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation
New England Journal of Medicine · 2005 · 10.1056/nejmoa050522
Impact of age on management and outcome of acute coronary syndrome: Observations from the global registry of acute coronary events (GRACE)
American Heart Journal · 2005 · 10.1016/j.ahj.2004.06.003
Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial Infarction
New England Journal of Medicine · 2001 · 10.1056/nejm200106213442503
Current projects
No projects listed.